3,4-dihydro-4-[(5-methyl-2-furanyl)methylene]-2H-pyrrole

Metabolite details

Identifier

BCWSVRKZMCXABS-TWGQIWQCSA-N

InChI Key

BCWSVRKZMCXABS-TWGQIWQCSA-N

IUPAC name

(4Z)-4-[(5-methylfuran-2-yl)methylidene]-3,4-dihydro-2H-pyrrole

Preferred name

3,4-dihydro-4-[(5-methyl-2-furanyl)methylene]-2H-pyrrole

INN name

—

Synonym

3-(5-Methylfurfurylidene)-1-pyrroline

ChEBI

CHEBI:134434

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Male_19_days_vs_Male_1_day
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d